MDM2 and Ewing sarcoma: MDM4 amplification is a possible mechanism for functional inactivation of the p53 pathway in Ewing Sarcoma given the infrequent occurrences of MDM2 amplification, CDKN2A deletion, or TP53 mutation in these cancers.